TY - JOUR
T1 - Epidemiology and etiology of blood stream infections in a Belgian burn wound center
AU - Costescu Strachinaru, Diana Isabela
AU - Gallez, Jean Luc
AU - François, Pierre Michel
AU - Baekelandt, Dries
AU - Paridaens, Marie Sophie
AU - Pirnay, Jean Paul
AU - De Vos, Daniel
AU - Djebara, Sarah
AU - Vanbrabant, Peter
AU - Strachinaru, Mihai
AU - Soentjens, Patrick
N1 - Publisher Copyright:
© Belgian Society of Internal Medicine and Royal Belgian Society of Laboratory Medicine (2021).
PY - 2022
Y1 - 2022
N2 - Background: Infections are a major cause of morbidity in burn patients. We aimed to investigate the epidemiology and antibiotic susceptibility of blood stream infections in order to gain a better understanding of their role and burden in our Burn Wound Center. Methods: This retrospective epidemiological investigation analyzed data derived from medical files of patients admitted to our Burn Wound Center having had at least one positive blood culture between 1 January and 31 December 2018. We focused on the prevalence of causative agents in blood stream infections in function of the time after injury and on their drug sensitivity. Results: Among the 363 patients admitted to our Burn Wound Center during the study period, 29 had at least one episode of blood stream infection. Gram-negative organisms accounted for 56,36% of the pathogens in blood stream infections, Gram-positives for 38,17%, and yeasts for 5,45%. Pseudomonas aeruginosa was the most common bacterium (20%), followed by Staphylococcus epidermidis (16.36%), Escherichia coli and Klebsiella pneumoniae (9,09% each). A third of the Gram-negative isolates were multidrug resistant. Gram-positive cocci were isolated from blood cultures at a median of 9 days after the injury, earlier than Gram-negative rods (median 15 days). The main sources of blood stream infections were the burn wounds, followed by infected catheters. Conclusions: Multidrug resistant bacteria must be considered when selecting empirical antibiotic therapy in septic burn patients. In our center, we need to update our antibiotic guidelines, to review the hospital infection control measures and to introduce routine typing technology.
AB - Background: Infections are a major cause of morbidity in burn patients. We aimed to investigate the epidemiology and antibiotic susceptibility of blood stream infections in order to gain a better understanding of their role and burden in our Burn Wound Center. Methods: This retrospective epidemiological investigation analyzed data derived from medical files of patients admitted to our Burn Wound Center having had at least one positive blood culture between 1 January and 31 December 2018. We focused on the prevalence of causative agents in blood stream infections in function of the time after injury and on their drug sensitivity. Results: Among the 363 patients admitted to our Burn Wound Center during the study period, 29 had at least one episode of blood stream infection. Gram-negative organisms accounted for 56,36% of the pathogens in blood stream infections, Gram-positives for 38,17%, and yeasts for 5,45%. Pseudomonas aeruginosa was the most common bacterium (20%), followed by Staphylococcus epidermidis (16.36%), Escherichia coli and Klebsiella pneumoniae (9,09% each). A third of the Gram-negative isolates were multidrug resistant. Gram-positive cocci were isolated from blood cultures at a median of 9 days after the injury, earlier than Gram-negative rods (median 15 days). The main sources of blood stream infections were the burn wounds, followed by infected catheters. Conclusions: Multidrug resistant bacteria must be considered when selecting empirical antibiotic therapy in septic burn patients. In our center, we need to update our antibiotic guidelines, to review the hospital infection control measures and to introduce routine typing technology.
KW - Burn wound
KW - ICU
KW - blood stream infection
KW - burn
KW - multidrug resistant
UR - http://www.scopus.com/inward/record.url?scp=85099353246&partnerID=8YFLogxK
U2 - 10.1080/17843286.2021.1872309
DO - 10.1080/17843286.2021.1872309
M3 - Article
C2 - 33432871
AN - SCOPUS:85099353246
SN - 1784-3286
VL - 77
SP - 353
EP - 359
JO - Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine
JF - Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine
IS - 2
ER -